Tamoxifen in advanced breast cancer.
Explore the source record for details and available documents.
Adult↗
Biomedical subjects
T Palshof
Publications and source records attributed to T Palshof.
[Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
Explore the source record for details and available documents.
Aged↗
Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Explore the source record for details and available documents.
Aged↗
Combination chemotherapy with CCNU, melphalan, methotrexate, and prednisone (CAMP) in 35 patients with advanced breast cancer.
Explore the source record for details and available documents.
Administration, Oral↗
Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.
Fifty-one postmenopausal patients with advanced breast cancer were randomized to receive either cyclophosphamide given continuously or cyclophosphamide given continuously with methotrexate, 5-fluorouracil, vincristine, and prednisone given intermittently. The results with the multiple-drug therapy were significantly better than with the single-drug therapy, both with regard to percentage (63% versus 25%) and median duration (400 versus 210 days) of objective response. Toxicity was moderately increased with the combination as compared to the single-drug treatment.
Aged↗